跳至主要内容
临床试验/JPRN-UMIN000031933
JPRN-UMIN000031933已完成4 期

GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) trial - GRACE-VAP trial

Division of Trauma and Surgical Critical Care, Osaka General Medical Center0 个研究点目标入组 206 人开始时间: 2018年3月28日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
206

研究概览

简要总结

Clinical response occurred in 79 patients (76.7%) in the Gram stain-guided group and 74 patients (71.8%) in the guideline-based group (risk difference, 0.05; 95% CI, -0.07 to 0.17; P < .001 for noninferiority). Reduced use of antipseudomonal agents (30.1%; 95% CI, 21.5%-39.9%; P < .001) and anti-MRSA agents (38.8%; 95% CI, 29.4%-48.9%; P < .001) was observed in the Gram stain-guided group vs guideline-based group.

研究设计

研究类型
Interventional

入排标准

年龄范围
15years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients will be excluded if they (1) have an allergy to study medications; (2) are pregnant; (3) have already been discharged from the ICU; (4) are diagnosed as having heart failure or atelectasis; (5) have been administered antibiotics for more than 24 hours when they meet the inclusion criteria; (6) are declined to provide full life support; or (7) are judged as inappropriate at the discretion of the study physician.

研究者

发起方
Division of Trauma and Surgical Critical Care, Osaka General Medical Center

相似试验